STOCK TITAN

[Form 4] Astera Labs, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Astera Labs insider transfer and holdings update. Director and President/COO Gajendra Sanjay reported transactions on 09/02/2025 moving 480,668 shares of common stock. The filing shows a corresponding reduction in directly held shares to 1,690,209 and an increase in indirectly beneficially owned shares to 6,006,213 held by three estate planning trusts. The Form 4 states the 480,668-share transfers to Trust 1 were for $0 and that Trusts 1–3 each hold 695,000 shares as described; the reporting person disclaims beneficial ownership of trust-held shares except for any pecuniary interest. The filing was signed by an attorney-in-fact on behalf of the reporting person.

Aggiornamento su trasferimenti e partecipazioni di Astera Labs da parte di un insider. Il direttore e Presidente/COO Gajendra Sanjay ha segnalato il 02/09/2025 operazioni che hanno trasferito 480.668 azioni ordinarie. La dichiarazione indica una riduzione delle azioni detenute direttamente a 1.690.209 e un aumento delle azioni detenute indirettamente a vantaggio di terzi a 6.006.213, detenute da tre trust per la pianificazione patrimoniale. Nel Modulo 4 si precisa che le 480.668 azioni trasferite al Trust 1 sono state cedute per $0 e che i Trust 1–3 detengono ciascuno 695.000 azioni come descritto; la persona che ha effettuato la segnalazione rinuncia alla proprietà beneficiaria delle azioni in trust, salvo eventuali interessi pecuniari. Il documento è stato sottoscritto da un procuratore per conto del dichiarante.

Actualización sobre transferencias y participaciones de un insider en Astera Labs. El director y presidente/COO Gajendra Sanjay informó operaciones el 02/09/2025 que movieron 480.668 acciones ordinarias. La presentación muestra una reducción de las acciones en propiedad directa a 1.690.209 y un aumento de las acciones poseídas de forma indirecta a 6.006.213, mantenidas por tres fideicomisos de planificación patrimonial. El Formulario 4 indica que las 480.668 acciones transferidas al Trust 1 se cedieron por $0 y que los Trusts 1–3 poseen cada uno 695.000 acciones según se describe; la persona informante niega la propiedad beneficiaria de las acciones en los fideicomisos salvo por cualquier interés pecuniario. La presentación fue firmada por un apoderado en nombre del informante.

Astera Labs 내부자 주식 이동 및 보유 현황 업데이트. 이사 겸 사장/COO인 Gajendra Sanjay는 2025-09-02에 보통주 480,668주를 이동한 거래를 보고했습니다. 제출서류에는 직접 보유 주식이 1,690,209주로 감소하고, 간접적으로 유익하게 보유한 주식이 6,006,213주로 증가했으며 이는 세 개의 유산 계획 신탁이 보유하고 있는 것으로 나와 있습니다. Form 4에는 Trust 1로의 480,668주 이전이 $0로 이루어졌고 Trust 1–3이 각각 695,000주를 보유한다고 설명되어 있습니다; 보고자는 신탁 보유 주식에 대한 수익적 소유권을 금전적 이해관계가 있는 경우를 제외하고 부인합니다. 해당 서류는 보고자를 대신한 대리인이 서명했습니다.

Mise à jour sur les transferts et les participations d'initié chez Astera Labs. Le directeur et président/COO Gajendra Sanjay a déclaré des opérations le 02/09/2025 déplaçant 480 668 actions ordinaires. Le dossier indique une réduction des actions détenues directement à 1 690 209 et une augmentation des actions détenues indirectement à 6 006 213, détenues par trois trusts de planification successorale. Le formulaire 4 précise que le transfert de 480 668 actions au Trust 1 a été effectué pour 0 $ et que les Trusts 1–3 détiennent chacun 695 000 actions comme décrit ; la personne déclarante décline la qualité de propriétaire bénéficiaire des actions détenues en trust, sauf pour tout intérêt pécuniaire. Le dépôt a été signé par un mandataire au nom de la personne déclarante.

Aktualisierung zu Insider-Transfers und -Beteiligungen bei Astera Labs. Direktor und Präsident/COO Gajendra Sanjay meldete am 02.09.2025 Transaktionen, bei denen 480.668 Stammaktien bewegt wurden. Die Einreichung weist eine Verringerung der direkt gehaltenen Aktien auf 1.690.209 und eine Erhöhung der indirekt wirtschaftlich gehaltenen Aktien auf 6.006.213 aus, die von drei Nachlassplanungstrusts gehalten werden. Im Formular 4 wird angegeben, dass die Übertragung von 480.668 Aktien an Trust 1 für $0 erfolgte und dass Trusts 1–3 jeweils 695.000 Aktien wie beschrieben halten; die meldende Person lehnt das wirtschaftliche Eigentum an den Trust-Aktien ab, sofern kein pecuniärer Anteil besteht. Die Einreichung wurde von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Insider moved shares into estate-planning trusts; direct holdings decreased while indirect holdings rose, per Form 4.

The Form 4 documents non-sales transfers of 480,668 shares on 09/02/2025 to an estate planning trust for no consideration, reducing direct ownership to 1,690,209 shares while reporting 6,006,213 shares indirectly owned across three trusts. This is a non-derivative securities transfer, not a market sale, and the filing includes standard disclaimers that the reporting person disclaims beneficial ownership of trust-held shares except to the extent of any pecuniary interest. For governance monitoring, the filing updates insider ownership figures and beneficial ownership structure without indicating a change in voting control disclosed in the form.

TL;DR: Filing documents a Section 16 change of beneficial ownership via trust transfers; disclosure complies with Form 4 reporting.

The report lists code G(1) transactions indicating transfers into a trust in which the reporting person is trustee. The Form 4 includes specific post-transaction balances: direct ownership of 1,690,209 shares and indirect ownership of 6,006,213 shares. The signature by an attorney-in-fact is provided with date. From a compliance standpoint, the form contains the required transaction codes, quantities, and explanatory remarks detailing trust ownership and disclaimers, fulfilling the reporting obligations reflected in the filing text.

Aggiornamento su trasferimenti e partecipazioni di Astera Labs da parte di un insider. Il direttore e Presidente/COO Gajendra Sanjay ha segnalato il 02/09/2025 operazioni che hanno trasferito 480.668 azioni ordinarie. La dichiarazione indica una riduzione delle azioni detenute direttamente a 1.690.209 e un aumento delle azioni detenute indirettamente a vantaggio di terzi a 6.006.213, detenute da tre trust per la pianificazione patrimoniale. Nel Modulo 4 si precisa che le 480.668 azioni trasferite al Trust 1 sono state cedute per $0 e che i Trust 1–3 detengono ciascuno 695.000 azioni come descritto; la persona che ha effettuato la segnalazione rinuncia alla proprietà beneficiaria delle azioni in trust, salvo eventuali interessi pecuniari. Il documento è stato sottoscritto da un procuratore per conto del dichiarante.

Actualización sobre transferencias y participaciones de un insider en Astera Labs. El director y presidente/COO Gajendra Sanjay informó operaciones el 02/09/2025 que movieron 480.668 acciones ordinarias. La presentación muestra una reducción de las acciones en propiedad directa a 1.690.209 y un aumento de las acciones poseídas de forma indirecta a 6.006.213, mantenidas por tres fideicomisos de planificación patrimonial. El Formulario 4 indica que las 480.668 acciones transferidas al Trust 1 se cedieron por $0 y que los Trusts 1–3 poseen cada uno 695.000 acciones según se describe; la persona informante niega la propiedad beneficiaria de las acciones en los fideicomisos salvo por cualquier interés pecuniario. La presentación fue firmada por un apoderado en nombre del informante.

Astera Labs 내부자 주식 이동 및 보유 현황 업데이트. 이사 겸 사장/COO인 Gajendra Sanjay는 2025-09-02에 보통주 480,668주를 이동한 거래를 보고했습니다. 제출서류에는 직접 보유 주식이 1,690,209주로 감소하고, 간접적으로 유익하게 보유한 주식이 6,006,213주로 증가했으며 이는 세 개의 유산 계획 신탁이 보유하고 있는 것으로 나와 있습니다. Form 4에는 Trust 1로의 480,668주 이전이 $0로 이루어졌고 Trust 1–3이 각각 695,000주를 보유한다고 설명되어 있습니다; 보고자는 신탁 보유 주식에 대한 수익적 소유권을 금전적 이해관계가 있는 경우를 제외하고 부인합니다. 해당 서류는 보고자를 대신한 대리인이 서명했습니다.

Mise à jour sur les transferts et les participations d'initié chez Astera Labs. Le directeur et président/COO Gajendra Sanjay a déclaré des opérations le 02/09/2025 déplaçant 480 668 actions ordinaires. Le dossier indique une réduction des actions détenues directement à 1 690 209 et une augmentation des actions détenues indirectement à 6 006 213, détenues par trois trusts de planification successorale. Le formulaire 4 précise que le transfert de 480 668 actions au Trust 1 a été effectué pour 0 $ et que les Trusts 1–3 détiennent chacun 695 000 actions comme décrit ; la personne déclarante décline la qualité de propriétaire bénéficiaire des actions détenues en trust, sauf pour tout intérêt pécuniaire. Le dépôt a été signé par un mandataire au nom de la personne déclarante.

Aktualisierung zu Insider-Transfers und -Beteiligungen bei Astera Labs. Direktor und Präsident/COO Gajendra Sanjay meldete am 02.09.2025 Transaktionen, bei denen 480.668 Stammaktien bewegt wurden. Die Einreichung weist eine Verringerung der direkt gehaltenen Aktien auf 1.690.209 und eine Erhöhung der indirekt wirtschaftlich gehaltenen Aktien auf 6.006.213 aus, die von drei Nachlassplanungstrusts gehalten werden. Im Formular 4 wird angegeben, dass die Übertragung von 480.668 Aktien an Trust 1 für $0 erfolgte und dass Trusts 1–3 jeweils 695.000 Aktien wie beschrieben halten; die meldende Person lehnt das wirtschaftliche Eigentum an den Trust-Aktien ab, sofern kein pecuniärer Anteil besteht. Die Einreichung wurde von einem Bevollmächtigten im Namen der meldenden Person unterzeichnet.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Gajendra Sanjay

(Last) (First) (Middle)
C/O ASTERA LABS, INC.
2345 NORTH FIRST STREET

(Street)
SAN JOSE CA 95131

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Astera Labs, Inc. [ ALAB ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
X Officer (give title below) Other (specify below)
President and COO
3. Date of Earliest Transaction (Month/Day/Year)
09/02/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 09/02/2025 G(1) 480,668 D $0 1,690,209 D
Common Stock 09/02/2025 G(1) 480,668 A $0 6,006,213 I By Trust 1(2)
Common Stock 695,000 I By Trust 2(3)
Common Stock 695,000 I By Trust 3(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. On September 2, 2025, the Reporting Person transferred 480,668 shares of Issuer Common Stock to an estate planning trust ("Trust 1") for no consideration.
2. These shares are owned directly by Trust 1, of which the Reporting Person is a trustee. The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
3. These shares are owned directly by an estate planning trust ("Trust 2"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
4. These shares are owned directly by an estate planning trust ("Trust 3"). The Reporting Person disclaims beneficial ownership of these securities, except to the extent, if any, of his pecuniary interest therein, and the filing of this Form 4 is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
Remarks:
/s/ Philip Mazzara, Attorney-in-Fact 09/04/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transactions did Gajendra Sanjay report on Form 4 for ALAB?

The filing reports transfers on 09/02/2025 of 480,668 shares to an estate planning trust (code G(1)) for $0 and updates post-transaction holdings.

How many ALAB shares does the reporting person directly and indirectly own after the transaction?

Post-transaction direct ownership is reported as 1,690,209 shares and indirect ownership is reported as 6,006,213 shares (held by trusts).

Were the transferred shares sold or transferred for consideration?

The Form 4 states the 480,668-share transfer to Trust 1 was for $0, indicating a transfer not a sale.

What trusts are referenced in the filing?

The filing references three estate planning trusts labeled Trust 1, Trust 2, and Trust 3, each described as holding specified shares with the reporting person disclaiming beneficial ownership except for any pecuniary interest.

Who signed the Form 4 and when?

The Form 4 was signed by Philip Mazzara, Attorney-in-Fact on 09/04/2025 on behalf of the reporting person.
ASTERA LABS INC

NASDAQ:ALAB

ALAB Rankings

ALAB Latest News

ALAB Latest SEC Filings

ALAB Stock Data

31.24B
144.18M
13.25%
72.56%
5.58%
Semiconductors
Semiconductors & Related Devices
Link
United States
SAN JOSE